Key result
MYH7 mutations are linked to ~7.4-fold higher odds of LVNC compared to controls.
Why the study?
Are loss-of-function mutations in NNT and rare variants in MYH7 associated with left ventricular noncompaction in humans and cardiac developmental defects in zebrafish?
Observational (n=56)
Single-blind
Are loss-of-function mutations in NNT and rare variants in MYH7 associated with left ventricular noncompaction in humans and cardiac developmental defects in zebrafish?
Answers are grounded in this paper and cite their sources.
This study identifies NNT as a novel candidate gene for left ventricular noncompaction acting via haploinsufficiency and aberrant cardiomyocyte proliferation, while demonstrating a higher-than-expected prevalence of MYH7 mutations (18.4%) in LVNC patients.
BACKGROUND: Left ventricular noncompaction (LVNC) is an autosomal-dominant, genetically heterogeneous cardiomyopathy with variable severity, which may co-occur with cardiac hypertrophy. METHODS AND RESULTS: Here, we generated whole exome sequence data from multiple members from 5 families with LVNC. In 4 of 5 families, the candidate causative mutation segregates with disease in known LVNC genes MYH7 and TPM1. Subsequent sequencing of MYH7 in a larger LVNC cohort identified 7 novel likely disease causing variants. In the fifth family, we identified a frameshift mutation in NNT, a nuclear-encoded mitochondrial protein, not implicated previously in human cardiomyopathies. Resequencing of NNT in additional LVNC families identified a second likely pathogenic missense allele. Suppression of nnt in zebrafish caused early ventricular malformation and contractility defects, probably driven by altered cardiomyocyte proliferation. In vivo complementation studies showed that mutant human NNT failed to rescue nnt morpholino-induced heart dysfunction, indicating a probable haploinsufficiency mechanism. CONCLUSIONS: Together, our data expand the genetic spectrum of LVNC and demonstrate how the intersection of whole exome sequence with in vivo functional studies can accelerate the identification of genes that drive human genetic disorders.
No takes yet. Share an insight, caveat, or question.
Bainbridge et al. (2015) conducted an observational in Left ventricular noncompaction (LVNC) (n=56). Loss-of-function mutations in NNT (and rare protein-changing mutations in MYH7) with in vivo zebrafish nnt morpholino suppression vs. Unselected control chromosomes / ARIC cohort (n=1,650) for genetics; wild-type human NNT mRNA rescue and uninjected controls in zebrafish was evaluated on Prevalence of rare, protein-changing MYH7 mutations in LVNC cohort vs ARIC control cohort (p=<0.0001). Loss-of-function mutations in NNT were identified in 2 LVNC families and failed to rescue morpholino-induced cardiac edema in zebrafish, while MYH7 mutations were enriched 7.4-fold in LVNC patients vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: